Evaluating New Chemistry to Drive Molecular Discovery: Fit for Purpose?

Abstract As our understanding of the impact of specific molecular properties on applications in discovery‐based disciplines improves, the extent to which published synthetic methods meet (or do not meet) desirable criteria is ever clearer. Herein, we show how the application of simple (and in many cases freely available) computational tools can be used to develop a semiquantitative understanding of the potential of new methods to support molecular discovery. This analysis can, among other things, inform the design of improved substrate scoping studies; direct the prioritization of specific exemplar structures for synthesis; and substantiate claims of potential future applications for new methods.

[1]  S. Zozulya,et al.  Design, synthesis, and characterization of SO2-containing azabicyclo[3.n.1]alkanes: promising building blocks for drug discovery. , 2015, Organic letters.

[2]  J. Bode,et al.  SnAP reagents for the synthesis of piperazines and morpholines. , 2014, Organic letters.

[3]  J. Delaney,et al.  Physical and Molecular Properties of Agrochemicals: An Analysis of Screen Inputs, Hits, Leads, and Products , 2003 .

[4]  G. V. Paolini,et al.  Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.

[5]  J. Mylne,et al.  An interactive database to explore herbicide physicochemical properties. , 2015, Organic & biomolecular chemistry.

[6]  Patrick J. Moon,et al.  Oxidative Coupling of Aryl Boron Reagents with sp(3)-Carbon Nucleophiles: The Enolate Chan-Evans-Lam Reaction. , 2016, Angewandte Chemie.

[7]  Nathan Brown,et al.  Plane of Best Fit: A Novel Method to Characterize the Three-Dimensionality of Molecules , 2012, J. Chem. Inf. Model..

[8]  E. Carreira,et al.  Construction of multifunctional modules for drug discovery: synthesis of novel thia/oxa-azaspiro[3.4]octanes. , 2013, Organic letters.

[9]  G. Molander,et al.  α-Arylation/Heteroarylation of Chiral α-Aminomethyltrifluoroborates by Synergistic Iridium Photoredox/Nickel Cross-Coupling Catalysis. , 2016, Angewandte Chemie.

[10]  C. Humblet,et al.  Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.

[11]  Jonas Boström,et al.  Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone? , 2016, Journal of medicinal chemistry.

[12]  Bespoke SnAP reagents for the synthesis of C-substituted spirocyclic and bicyclic saturated N-heterocycles. , 2015, Organic letters.

[13]  J. Bode,et al.  SnAP reagents for the one-step synthesis of medium-ring saturated N-heterocycles from aldehydes. , 2014, Nature chemistry.

[14]  Phil S. Baran,et al.  Academia–Industry Symbiosis in Organic Chemistry , 2015, Accounts of chemical research.

[15]  T. Atack,et al.  Iron-catalyzed borylation of alkyl electrophiles. , 2014, Journal of the American Chemical Society.

[16]  Jonas Boström,et al.  Understanding our love affair with p-chlorophenyl: present day implications from historical biases of reagent selection. , 2015, Journal of medicinal chemistry.

[17]  Sukbok Chang,et al.  [Cu(NHC)]-Catalyzed C-H Allylation and Alkenylation of both Electron-Deficient and Electron-Rich (Hetero)arenes with Allyl Halides. , 2016, Angewandte Chemie.

[18]  R. Grubbs,et al.  Silylation of C–H bonds in aromatic heterocycles by an Earth-abundant metal catalyst , 2015, Nature.

[19]  Katie Kingwell.  European Lead Factory hits its stride , 2016, Nature Reviews Drug Discovery.

[20]  Thorsten Meinl,et al.  KNIME-CDK: Workflow-driven cheminformatics , 2013, BMC Bioinformatics.

[21]  A. Nadin,et al.  Leitstruktur‐orientierte Synthese: eine Alternative für die Synthesechemie , 2012 .

[22]  C. Lipinski.  Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.

[23]  Jean-Louis Reymond,et al.  Enumeration of 166 Billion Organic Small Molecules in the Chemical Universe Database GDB-17 , 2012, J. Chem. Inf. Model..

[24]  William Lewis,et al.  Combining two-directional synthesis and tandem reactions. Part 21: Exploitation of a dimeric macrocycle for chain terminus differentiation and synthesis of an sp(3)-rich library. , 2015, Bioorganic & medicinal chemistry.

[25]  Adam Nelson,et al.  A unified lead-oriented synthesis of over fifty molecular scaffolds. , 2015, Organic & biomolecular chemistry.

[26]  W Patrick Walters,et al.  What do medicinal chemists actually make? A 50-year retrospective. , 2011, Journal of medicinal chemistry.

[27]  T. Ritchie,et al.  The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design? , 2009, Drug discovery today.

[28]  Matthew W D Perry,et al.  Designing novel building blocks is an overlooked strategy to improve compound quality. , 2015, Drug discovery today.

[29]  A. H. Lipkus,et al.  Structural Diversity of Organic Chemistry. a Scaffold Analysis of the Cas Registry , 2022 .

[30]  Frank Glorius,et al.  Intermolecular reaction screening as a tool for reaction evaluation. , 2015, Accounts of chemical research.

[31]  W. Lewis,et al.  Facile access to a heterocyclic, sp(3)-rich chemical scaffold via a tandem condensation/intramolecular nitrone-alkene [3+2] cycloaddition strategy. , 2015, Chemical communications.

[32]  Thomas E Nielsen,et al.  Synthesis of 1,4,5 trisubstituted γ-lactams via a 3-component cascade reaction. , 2015, Bioorganic & medicinal chemistry.

[33]  D. Spring,et al.  A diversity-oriented synthesis strategy enabling the combinatorial-type variation of macrocyclic peptidomimetic scaffolds , 2015, Organic & biomolecular chemistry.

[34]  Simon J F Macdonald,et al.  Factors determining the selection of organic reactions by medicinal chemists and the use of these reactions in arrays (small focused libraries). , 2010, Angewandte Chemie.

[35]  H. Pajouhesh,et al.  Medicinal chemical properties of successful central nervous system drugs , 2005, NeuroRX.

[36]  S. F. Macdonald,et al.  Faktoren für die Auswahl organischer Reaktionen in der medizinischen Chemie und die Anwendung dieser Reaktionen in Arrays (kleinen fokussierten Bibliotheken) , 2010 .

[37]  Shuj Kobayashi,et al.  Chiral Metal Nanoparticle Systems as Heterogeneous Catalysts beyond Homogeneous Metal Complex Catalysts for Asymmetric Addition of Arylboronic Acids to α,β-Unsaturated Carbonyl Compounds. , 2015, Journal of the American Chemical Society.

[38]  M. Rasmussen,et al.  Synthesis of (Arylamido)pyrrolidinone Libraries through Ritter‐Type Cascade Reactions of Dihydroxylactams , 2015 .

[39]  C. W. Murray,et al.  Organische Chemie für die fragmentbasierte Wirkstoffentwicklung (FBDD) , 2016 .

[40]  Nathan Brown,et al.  Fragment-based hit identification: thinking in 3D. , 2013, Drug discovery today.

[41]  Giovanni Muncipinto,et al.  Synthesis and profiling of a diverse collection of azetidine-based scaffolds for the development of CNS-focused lead-like libraries. , 2012, The Journal of organic chemistry.

[42]  O. Grygorenko,et al.  Toward lead-oriented synthesis: one-pot version of Castagnoli condensation with nonactivated alicyclic anhydrides. , 2014, ACS combinatorial science.

[43]  Frank Glorius,et al.  A robustness screen for the rapid assessment of chemical reactions , 2013, Nature Chemistry.

[44]  Adam Nelson,et al.  Design, synthesis and decoration of molecular scaffolds for exploitation in the production of alkaloid-like libraries. , 2015, Bioorganic & medicinal chemistry.

[45]  Christopher W Murray,et al.  Opportunity Knocks: Organic Chemistry for Fragment-Based Drug Discovery (FBDD). , 2016, Angewandte Chemie.

[46]  Hanno Wild,et al.  The importance of chemistry for the future of the pharma industry. , 2011, Angewandte Chemie.

[47]  Peter O'Brien,et al.  Lead-oriented synthesis: Investigation of organolithium-mediated routes to 3-D scaffolds and 3-D shape analysis of a virtual lead-like library. , 2015, Bioorganic & medicinal chemistry.

[48]  Frank Glorius,et al.  Application of a robustness screen for the evaluation of synthetic organic methodology , 2014, Nature Protocols.

[49]  P. O’Brien,et al.  From Heteroaromatic Acids and Imines to Azaspirocycles: Stereoselective Synthesis and 3D Shape Analysis , 2016, Chemistry.

[50]  Adam Nelson,et al.  A divergent synthetic approach to diverse molecular scaffolds: assessment of lead-likeness using LLAMA, an open-access computational tool. , 2016, Chemical communications.

[51]  M. Willis,et al.  Combining Organometallic Reagents, the Sulfur Dioxide Surrogate DABSO, and Amines: A One-Pot Preparation of Sulfonamides, Amenable to Array Synthesis** , 2014, Angewandte Chemie.

[52]  Hanno Wild,et al.  Editorial: Die Bedeutung der Chemie für die Zukunft der Pharmaindustrie , 2011 .

[53]  O. A. Davis,et al.  Synthesis of diversely functionalised 2,2-disubstituted oxetanes: fragment motifs in new chemical space. , 2015, Chemical communications.

[54]  P. Verhoest,et al.  Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes. , 2010, ACS chemical neuroscience.

[55]  Channa K. Hattotuwagama,et al.  Lead-oriented synthesis: a new opportunity for synthetic chemistry. , 2012, Angewandte Chemie.

[56]  Adam Nelson,et al.  A systematic approach to diverse, lead-like scaffolds from α,α-disubstituted amino acids. , 2015, Chemical communications.

[57]  J. Bull,et al.  Synthesis of Di-, Tri-, and Tetrasubstituted Oxetanes by Rhodium-Catalyzed O=H Insertion and C=C Bond-Forming Cyclization** , 2014, Angewandte Chemie.

[58]  Adam Nelson,et al.  Expansion of chemical space for collaborative lead generation and drug discovery: the European Lead Factory Perspective. , 2015, Drug discovery today.

[59]  J. Wolfe.  Palladium-Catalyzed Carboetherification and Carboamination Reactions of γ-Hydroxy- and γ-Aminoalkenes for the Synthesis of Tetrahydrofurans and Pyrrolidines. , 2007, European journal of organic chemistry.

[60]  Andrew Plant,et al.  Current Challenges and Trends in the Discovery of Agrochemicals , 2013, Science.

[61]  Yanying Wang,et al.  Physicochemical Profiles of the Marketed Agrochemicals and Clues for Agrochemical Lead Discovery and Screening Library Development , 2015, Molecular informatics.

[62]  John P Wolfe,et al.  Mild conditions for the synthesis of functionalized pyrrolidines via Pd-catalyzed carboamination reactions. , 2007, Organic letters.

[63]  J. Bode,et al.  Catalytic Synthesis of N-Unprotected Piperazines, Morpholines, and Thiomorpholines from Aldehydes and SnAP Reagents. , 2015, Angewandte Chemie.

[64]  J. Bode,et al.  One-step synthesis of saturated spirocyclic N-heterocycles with stannyl amine protocol (SnAP) reagents and ketones. , 2014, Journal of the American Chemical Society.

[65]  Claude Ostermann,et al.  De novo branching cascades for structural and functional diversity in small molecules , 2015, Nature Communications.

[66]  P. Verhoest,et al.  Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties. , 2010, ACS Chemical Neuroscience.